98 related articles for article (PubMed ID: 1803775)
1. [The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis].
Grigorian SS; Pritsker AD; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):407-9. PubMed ID: 1803775
[TBL] [Abstract][Full Text] [Related]
2. [The interferon status and circulating immunoglobulins during the interferon therapy of respiratory papillomatosis in children].
Pritsker AD; Grigorian SS; Onufrieva SS; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):411-4. PubMed ID: 1725077
[TBL] [Abstract][Full Text] [Related]
3. [Natural killer activity in respiratory papillomatosis and its changes after interferon treatment].
Pritsker AD; Grigorian SS; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):409-11. PubMed ID: 1803776
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
[TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.
Naiman HB; Doyle AT; Ruben RJ; Kadish AS
Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):483-7. PubMed ID: 6437314
[TBL] [Abstract][Full Text] [Related]
6. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies against alpha-2 and gamma-interferons affect the course of juvenile respiratory papillomatosis in children treated with alpha-2 interferon preparations].
Kol'tsov VD; Onufrieva EK; Nurmukhamedov RKh; Malinovskaya VV; Yershov FI
Vestn Otorinolaringol; 1997; (4):13-5. PubMed ID: 9334008
[TBL] [Abstract][Full Text] [Related]
8. Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
Thurmond LM; Brand CM; Leventhal BG; Finter NB; Johnston JM
J Lab Clin Med; 1991 Sep; 118(3):232-40. PubMed ID: 1919296
[TBL] [Abstract][Full Text] [Related]
9. [Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].
Garashchenko TI; Markova TP; Chuvirov DG
Vestn Otorinolaringol; 1996; (4):15-8. PubMed ID: 8966870
[TBL] [Abstract][Full Text] [Related]
10. [Producer cells of human alpha and gamma interferons].
Orlova TG; Solov'eva MN; Slavina EG; Kognovitskaia AI; Mamontova TV; Kulieva AM; Shcheglovitova ON
Vopr Virusol; 1990; 35(3):213-5. PubMed ID: 2120852
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions.
Kashima H; Leventhal B; Clark K; Cohen S; Dedo H; Donovan D; Fearon B; Gardiner L; Goepfert H; Lusk R
Laryngoscope; 1988 Mar; 98(3):334-40. PubMed ID: 3278186
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies to alpha-2A interferon in children with juvenile respiratory papillomatosis].
Kol'tsov VD; Onufrieva EK; Chireshkin DG; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1995; (5):24-6. PubMed ID: 7502448
[TBL] [Abstract][Full Text] [Related]
13. [The disturbance of human lymphocyte production of interleukin-2 and gamma-interferon during stress and the mechanisms of their interaction].
Gotovtseva EP; Serov IV; Uchakin PN; Shestakova SV; Surkina ID; Ershov FI
Vopr Virusol; 1990; 35(5):435-7. PubMed ID: 2125163
[No Abstract] [Full Text] [Related]
14. [The interferon system of children with enterobiasis].
Makarova MG; Doskin VA; Makarova ZS; Dzhumigo PA; Ershov FI; Sergiev VP; Malinovskaia VV; Babaian SS
Med Parazitol (Mosk); 1995; (3):56-7. PubMed ID: 7476687
[No Abstract] [Full Text] [Related]
15. [The effect of lead nitrate on the interferon production by somatic and lymphoid cells in the mouse].
Zhumatova BKh; Aspetov RD; Kalieva NA; Nemenko BA
Vopr Virusol; 1990; 35(5):419-20. PubMed ID: 2125162
[No Abstract] [Full Text] [Related]
16. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.
Healy GB; Gelber RD; Trowbridge AL; Grundfast KM; Ruben RJ; Price KN
N Engl J Med; 1988 Aug; 319(7):401-7. PubMed ID: 3398891
[TBL] [Abstract][Full Text] [Related]
17. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study.
Stern Y; Felipovich A; Cotton RT; Segal K
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):169-71. PubMed ID: 17419519
[TBL] [Abstract][Full Text] [Related]
18. Side effects and toxicity of interferon in the treatment of recurrent respiratory papillomatosis.
Crockett DM; McCabe BF; Lusk RP; Mixon JH
Ann Otol Rhinol Laryngol; 1987; 96(5):601-7. PubMed ID: 3674659
[TBL] [Abstract][Full Text] [Related]
19. [Activation of phagocytosis by preparations of human alpha and gamma interferons].
Vakhrameeva NS; Avdeeva ZhE; Kuznetsov VP; Bobkova EV; Krylov OR
Vopr Virusol; 1988; 33(2):181-4. PubMed ID: 3137727
[TBL] [Abstract][Full Text] [Related]
20. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment].
Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM
Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
